SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biocryst Pharmaceuticals Inc (BCRX) -- Ignore unavailable to you. Want to Upgrade?

To: Archie Meeties who wrote (177)9/20/2007 6:07:34 PM
From: scaram(o)uche  Read Replies (3) | Respond to of 269
 
lightning fast study, blinded data must have looked all over map. this is obviously data mining, and Stonehouse knows the sort of light that it shines on the company. questions are, is this needle bit just b.s. and will Stonehouse be able to build, quickly, on this Buggy infrastructure?

it's not like he was hiding the fact that they went to the literature to try to explain the data mining. that took guts, fielding that conference call.

:-(

I know nada about i.m. injection and small molecules. It's usually the realm of vaccines and complement-fixing biologicals.



To: Archie Meeties who wrote (177)9/20/2007 7:27:32 PM
From: Ian@SI  Respond to of 269
 
EDIT: I see you and Rick have already discussed more than I could guess at. I should have read the thread before trying to reply.

+++++++++++++++++++

I don't believe it was explicitly stated during the conference call but it may have been a post hoc measurement.

... or it may not have been analyzed and reported in a timely fashion.

I don't know the answer. Perhaps IR could help you.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News